Sandoz Group AG Eyes Strategic Growth with Potential Acquisition of Just-Evotec Biologics
Sandoz Group AG has announced a potential acquisition of Just-Evotec Biologics, a biologics development and manufacturing facility in France, in a deal valued at approximately $300 million.
2 minutes to read